8-K/A XBRL

8-K/A

Company: SUPERNUS PHARMACEUTICALS, INC.
Filed: February 10, 2022
Period of Report: February 10, 2022
Accession Number: 0001356576-22-000004

View Document ↗ View on SEC.gov ↗